Trade-off of risk and benefit of finerenone across the spectrum of kidney function in patients with heart failure with mildly reduced and preserved ejection fraction in the FINEARTS-HF trial
17 May 2025 (08:00 - 12:45)
Organised by: 
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
6 More presentations in this session
Doctor A. Bhatt (San Francisco, US)
Doctor M. Karakas (Hamburg, DE)
Doctor K. Docherty (Glasgow, GB)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025
You may be interested in
Congress Presentation
